![](/-/media/icons/2019/pharma/biomedtracker-icon.png?rev=fc7926a0385c4901b67c1887d9aac276)
Series C brings in $28.5mm for Baxano
Executive Summary
Spinal device company Baxano Inc. has raised $28.5mm out of a potential $30mm in its Series C equity financing led by first-time backer CMEA Capital, which was joined by other new investors Kaiser Permanente Ventures and Affinity Capital Management, returning shareholders Prospect Venture Partners, Three Arch Partners, and Kearny Venture Partners, and six undisclosed investors. The company will apply the money towards the US launch of its iO-Flex system for lumbar stenosis and for post-clearance clinical trials.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice